Contract Organizations Impacting Pharma Development and Manufacturing

Facts and Figures

Medical Marijuana: Is it a blessing in disguise...

The influx of companies, the launch of pipeline therapies, and the legalization of marijuana/ cannabis are the major drivers of the medical marijuana market. Cannabis, popularly known as Marijuana,...

Aug 10, 2020

Hereditary Transthyretin Amyloidosis Market | hATTR Market Size | hATTR
Unfolding The Folds Of Transthyretin

The Hereditary Transthyretin Amyloidosis (hATTR) Market size in the 7MM was estimated to be USD 306.9 Million in 2017 and is anticipated to grow further in the forecast period 2020-30 owing to recent approvals and pipeline therapies.Among the 7MM geographies, the US accounted for the 54% share of the total hATTR ma...

Find More
Adrenoleukodystrophy Market | ALD Market
A Complex Chromosomal Abberation Called Adrenoleukodystrophy

The global Adrenoleukodystrophy market size for the forecast period 2020-30, which was estimated to be USD 922.43 million in the 7MM in 2017 is driven by key pharma players such as Bluebird Bio, Minoryx Therapeutics, MedDay Pharmaceuticals, Magenta Therapeutics, and others are proactively focusing on advancing ALD ...

Find More
Frontotemporal-dementia-market
Addressing The Scattered Harbingers of Frontotemporal Dementia

The Frontotemporal dementia market is expected to increase with a CAGR of 21.41% for 7MM during the study period. However, pharma companies such as TauRx Therapeutics, Axon Neuroscience SE, Prevail Therapeutics, Avid Radiopharmaceuticals, and Alector are actively working to buildup the Frontotemporal dementia pipel...

Find More

More Views & Analysis

Familial Chylomicronemia Syndrome Market
Rejections and Withdrawals: Familial Chylomicronemia Syndrome Market Needs a Therapy sufficiently Effective, sufficiently Affordable

A rare autosomal recessive disorder, Familial chylomicronemia syndrome (FCS) affects 1 in 1 to 2 million people (Burnett and Hegele, 1999; Pouwels et al. 2008). As per DelveInsight, the total Familial chylomicronemia syndrome diagnosed prevalent population in the 7MM [the US, EU4 (Germany, Franc...

Find More

Acute Kidney Injury Pipeline
Watch Out for the Most Promising Therapies in the Pipeline in Acute Kidney Injury Market

The Acute Kidney Injury Therapies in the pipeline anticipated to launch in the next decade shall spur the AKI Market growth forward. Acute Kidney Injury (AKI) is defined as a sudden advent of kidney failure or damage due to the accumulation of waste products in the bloodstream resulting in the improper fluid ou...

Find More

Vernal-keratoconjunctivitis-VKC-Market-Size-and-Share
An Eye-Blinding Scenario of Vernal keratoconjunctivitis

The present Vernal keratoconjunctivitis market size in all the markets (the US, EU-5 (Germany, France, Italy, Spain, United Kingdom), Japan, China, MEA (Saudi Arabia, Egypt), and Russia) was estimated to be USD 307.89 million in 2017 and is anticipated to increase further by 2030 owing to recent advances in technol...

Find More

Metabolic Acidosis Market | MA Market
Metabolic Acidosis: Counting The Unmeasured Anions And Closing the Gap In Blood Serum

Metabolic Acidosis Market offers immense opportunities to the pharma players to explore, which currently is dominated by alkali therapies and lacks any approved therapy. Launch of Pipeline therapies and rising prevalence shall accelerate the MA market growth in 7MM+3EM by 2030. An acid-base disorder, Metabolic...

Find More

Postpartum Depression Market | PPD Market
Spot the Signs and Fight Postpartum Depressions

The Postpartum Depression Market Size in the 7MM was estimated to be USD 138.75 Million in 2017 and is expected to grow further with rise in PPD prevalence and immense opportunities with only a single marketed therapy available. Depression is one of the most common complications of pregnancy. During or after p...

Find More

Nontuberculous Mycobacterial Infection Market | NTM Infection Market
Rising Nontuberculous Mycobacterial Infection Prevalence Poses A Major Public Health Concern

The Nontuberculous mycobacterial infection market worth is expected to grow at a CAGR of 6.6% by 2030 owing to robust NTM infection pipeline, rising prevalence among immunocompromised as well as immunocompetent populations, and a considerable shift towards branded therapeutics options. Planet Earth hosts a dive...

Find More

Digital therapies are evidence-based clinical approaches powered by software applications designed t.....

Find More

A rare glomerular kidney-scarring disease, Focal Segmental Glomerulosclerosis (FSGS) is a disease wi.....

Find More

Raynaud’s phenomenon (RP) is a condition that results in discoloration of fingers or toes caused b.....

Find More

Lamellar Ichthyosis (LI) is an autosomal recessive congenital Ichthyosis (ARCI), which mainly affect.....

Find More

Asthma is a chronic disease of the air passages characterized by inflammation and narrowing of the a.....

Find More

Sanitization is a key factor in rural and urban India. The lack of adequate sanitization is a very p.....

Find More